This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
B-cell lymphoma proteins 3D structures
From Proteopedia
(Difference between revisions)
| Line 14: | Line 14: | ||
**[[2mej]] - hBcl-xL + p53 - NMR<br /> | **[[2mej]] - hBcl-xL + p53 - NMR<br /> | ||
**[[6lhd]] - hBcl-xL/p53 <br /> | **[[6lhd]] - hBcl-xL/p53 <br /> | ||
| - | **[[1ysg]], [[3sp7]], [[3spf]], [[3wiz]], [[4tuh]], [[3zln]], [[3zk6]], [[3zlo]], [[3zlr]], [[4c52]], [[4c5d]], [[2yxj]], [[4qnq]], [[4qvx]], [[6rnu]], [[6vwc]], [[7jgv]], [[7jgw]] - hBcl-xL + inhibitor<br /> | + | **[[1ysg]], [[3sp7]], [[3spf]], [[3wiz]], [[4tuh]], [[3zln]], [[3zk6]], [[3zlo]], [[3zlr]], [[4c52]], [[4c5d]], [[2yxj]], [[4qnq]], [[4qvx]], [[6rnu]], [[6vwc]], [[7jgv]], [[7jgw]], [[7lh7]] - hBcl-xL + inhibitor<br /> |
| + | **[[7xgf]] - hBcl-xL + inhibitor protein<br /> | ||
**[[3inq]] - hBcl-xL (mutant) + inhibitor<br /> | **[[3inq]] - hBcl-xL (mutant) + inhibitor<br /> | ||
**[[2w3l]] – hBcl-xL + quinoline derivative<br /> | **[[2w3l]] – hBcl-xL + quinoline derivative<br /> | ||
| Line 41: | Line 42: | ||
**[[5b1z]] - hBcl-xL + BHX BH3 domain<br /> | **[[5b1z]] - hBcl-xL + BHX BH3 domain<br /> | ||
**[[4z9v]] - hBcl-xL + TCTP BH3 domain<br /> | **[[4z9v]] - hBcl-xL + TCTP BH3 domain<br /> | ||
| + | **[[7wjh]] - hBcl-xL + Pxt1 BH3 domain<br /> | ||
**[[6dcn]], [[6dco]] - hBcl-xL + Beclin-1 BH3 domain<br /> | **[[6dcn]], [[6dco]] - hBcl-xL + Beclin-1 BH3 domain<br /> | ||
**[[2p1l]] - hBcl-xL (mutant) + Beclin-1 BH3 domain<br /> | **[[2p1l]] - hBcl-xL (mutant) + Beclin-1 BH3 domain<br /> | ||
| Line 59: | Line 61: | ||
**[[4aq3]], [[4man]], [[5jsn]], [[4ieh]], [[6gl8]], [[6qgg]], [[6qgj]], [[6qgk]], [[7jmt]] – hBcl-2 + inhibitor<br /> | **[[4aq3]], [[4man]], [[5jsn]], [[4ieh]], [[6gl8]], [[6qgg]], [[6qgj]], [[6qgk]], [[7jmt]] – hBcl-2 + inhibitor<br /> | ||
**[[4lvt]], [[4lxd]], [[6o0k]], [[6o0m]], [[6o0o]], [[6o0p]] – hBcl-2 (mutant) + inhibitor<br /> | **[[4lvt]], [[4lxd]], [[6o0k]], [[6o0m]], [[6o0o]], [[6o0p]] – hBcl-2 (mutant) + inhibitor<br /> | ||
| - | **[[7lhb]] – hBcl-2 + drug<br /> | + | **[[7lhb]] – hBcl-2 (mutant) + drug<br /> |
**[[5fcg]] – hBcl-2 (mutant) + HBX BH3 domain<br /> | **[[5fcg]] – hBcl-2 (mutant) + HBX BH3 domain<br /> | ||
**[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator Bax BH3 domain<br /> | **[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator Bax BH3 domain<br /> | ||
| Line 139: | Line 141: | ||
**[[5fmi]], [[4u2u]], [[5vx1]] – hBak (mutant)<br /> | **[[5fmi]], [[4u2u]], [[5vx1]] – hBak (mutant)<br /> | ||
**[[4u2v]] – hBak/GFP<br /> | **[[4u2v]] – hBak/GFP<br /> | ||
| + | **[[7ofm]], [[7ofo]] – hBak transmembrane helix - NMR<br /> | ||
**[[3qbr]] - hBak + sjA<br /> | **[[3qbr]] - hBak + sjA<br /> | ||
**[[6uxm]], [[6uxn]], [[6uxo]], [[6uxp]], [[6uxq]], [[6uxr]] - hBak + inhibitor<br /> | **[[6uxm]], [[6uxn]], [[6uxo]], [[6uxp]], [[6uxq]], [[6uxr]] - hBak + inhibitor<br /> | ||
| Line 145: | Line 148: | ||
**[[5vwv]] - hBak (mutant)+ BIM BH3 domain<br /> | **[[5vwv]] - hBak (mutant)+ BIM BH3 domain<br /> | ||
**[[2m5b]] - hBak + BID BH3 domain - NMR<br /> | **[[2m5b]] - hBak + BID BH3 domain - NMR<br /> | ||
| + | **[[7m5c]] – hBak + Bak BH3 peptide<br /> | ||
| + | **[[7m5a]], [[7m5b]] – hBak + M3W5 BID<br /> | ||
| + | **[[7lk4]] – hBak (mutant) + antibody<br /> | ||
**[[6mcy]] – mBak<br /> | **[[6mcy]] – mBak<br /> | ||
| Line 157: | Line 163: | ||
**[[2nl9]] – hBim + Mcl-1<br /> | **[[2nl9]] – hBim + Mcl-1<br /> | ||
**[[6x8o]] – hBim BH3 peptide<br /> | **[[6x8o]] – hBim BH3 peptide<br /> | ||
| + | |||
| + | *Bcl-2-like protein 15 | ||
| + | |||
| + | **[[7ccl]], [[7ccm]] - hBcl-2-L-15<br /> | ||
Mcl-1 (Bcl-2-like protein 3 or Myeloid cell leukemia-1) | Mcl-1 (Bcl-2-like protein 3 or Myeloid cell leukemia-1) | ||
| Line 167: | Line 177: | ||
**[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand<br /> | **[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand<br /> | ||
**[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam<br /> | **[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam<br /> | ||
| - | **[[3wix]], [[3wiy]], [[4oq5]], [[4oq6]], [[4hw2]], [[4hw3]], [[4hw4]], [[4wmr]], [[4zbf]], [[4zbi]], [[5fc4]], [[5fdo]], [[5fdr]], [[5iez]], [[5if4]], [[5jsb]], [[5ku9]], [[5vkc]], [[6b4l]], [[6b4u]], [[6bw2]], [[6bw8]], [[6fs1]], [[6fs2]], [[6ne5]], [[6o4u]], [[6o6f]], [[6oqb]], [[6oqc]], [[6oqd]], [[6oqn]], [[6p3p]], [[6qgd]], [[6qfq]], [[6qyp]], [[6qz5]], [[6qz6]], [[6qz8]], [[6qzb]], [[6u63]], [[6u64]], [[6u65]], [[6u67]], [[6u6f]], [[6ud2]], [[6udi]], [[6udt]], [[6udu]], [[6udv]], [[6udx]], [[6udy]], [[6ybg]] - hMcl-1 residues 174-324 + inhibitor<br /> | + | **[[3wix]], [[3wiy]], [[4oq5]], [[4oq6]], [[4hw2]], [[4hw3]], [[4hw4]], [[4wmr]], [[4zbf]], [[4zbi]], [[5fc4]], [[5fdo]], [[5fdr]], [[5iez]], [[5if4]], [[5jsb]], [[5ku9]], [[5vkc]], [[6b4l]], [[6b4u]], [[6bw2]], [[6bw8]], [[6fs1]], [[6fs2]], [[6ne5]], [[6o4u]], [[6o6f]], [[6oqb]], [[6oqc]], [[6oqd]], [[6oqn]], [[6p3p]], [[6qgd]], [[6qfq]], [[6qyp]], [[6qz5]], [[6qz6]], [[6qz8]], [[6qzb]], [[6u63]], [[6u64]], [[6u65]], [[6u67]], [[6u6f]], [[6ud2]], [[6udi]], [[6udt]], [[6udu]], [[6udv]], [[6udx]], [[6udy]], [[6ybg]], [[7nb4]], [[7nb7]] - hMcl-1 residues 174-324 + inhibitor<br /> |
| + | **[[7xge]], [[7xgg]] - hMcl-1 residues 174-324 + protein inhibitor<br /> | ||
**[[6ovc]] - hMcl-1 residues 174-324 + inhibitor - NMR<br /> | **[[6ovc]] - hMcl-1 residues 174-324 + inhibitor - NMR<br /> | ||
**[[6qxj]], [[6qyk]], [[6qyl]], [[6qyn]], [[6qyo]], [[6qz7]], [[6ybj]], [[6ybk]], [[6ybl]] - hMcl-1 residues 174-324/MBP + inhibitor<br /> | **[[6qxj]], [[6qyk]], [[6qyl]], [[6qyn]], [[6qyo]], [[6qz7]], [[6ybj]], [[6ybk]], [[6ybl]] - hMcl-1 residues 174-324/MBP + inhibitor<br /> | ||
| Line 196: | Line 207: | ||
**[[2o42]], [[2jbx]] – MvM11L – Myxoma virus<br /> | **[[2o42]], [[2jbx]] – MvM11L – Myxoma virus<br /> | ||
| - | **[[2jby]] – MvM11L + | + | **[[2jby]] – MvM11L + Bak <br /> |
**[[3dvu]], [[3bl2]], [[4mi8]] – M11 + Beclin-1 – Murid herpesvirus<br /> | **[[3dvu]], [[3bl2]], [[4mi8]] – M11 + Beclin-1 – Murid herpesvirus<br /> | ||
Current revision
3D structures of B-cell lymphoma proteins
Updated on 27-October-2022
Mcl-1 (Bcl-2-like protein 3 or Myeloid cell leukemia-1)
